0002103906-26-000002.txt : 20261109 0002103906-26-000002.hdr.sgml : 20261109 20261109145506 ACCESSION NUMBER: 0002103906-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20261109 DATE AS OF CHANGE: 20261109 EFFECTIVENESS DATE: 20261109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NBO Pharma Inc. CENTRAL INDEX KEY: 0002103906 ORGANIZATION NAME: EIN: 862318348 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-604113 FILM NUMBER: 261535517 BUSINESS ADDRESS: STREET 1: 64 QUARRY LANE CITY: BEDFORD STATE: NY ZIP: 10506 BUSINESS PHONE: 914-645-1130 MAIL ADDRESS: STREET 1: 64 QUARRY LANE CITY: BEDFORD STATE: NY ZIP: 10506 D 1 primary_doc.xml X0708 D LIVE 0002103906 NBO Pharma Inc. 64 QUARRY LANE BEDFORD NY NEW YORK 10506 914-645-1130 DELAWARE NBO Pharma LLC None Corporation true Fredric David Price 64 Quarry Lane Bedford NY NEW YORK 10506 Executive Officer Director Robert Friedman 64 Quarry Lane Bedford NY NEW YORK 10506 Director Colin Foster 64 Quarry Lane Bedford NY NEW YORK 10506 Director Bard Geesaman 64 Quarry Lane Bedford NY NEW YORK 10506 Director Pharmaceuticals Decline to Disclose 06c false 2026-11-02 false true true false 0 Paulson Investment Company, LLC 5670 None None 10220 SW Greenburg Road Suite 380 Portland OR OREGON 97223 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS KY KENTUCKY MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MT MONTANA NV NEVADA NJ NEW JERSEY NY NEW YORK OH OHIO OR OREGON PA PENNSYLVANIA SD SOUTH DAKOTA TX TEXAS VA VIRGINIA WA WASHINGTON false 7000000 238000 6762000 false 5 960000 0 Issuer will provide placement agent (i) 13% of gross proceeds received from qualifying investors, (ii) a $50,000 expense fee, and (iii) 15% PA warrant coverage. Commissions estimate assumes full $7MM offering amount is sold to qualifying investors. 0 false NBO Pharma Inc. /s/ Fredric D. Price Fredric D. Price Chief Executive Officer 2026-11-09